On the heels of receiving FDA clearance for its first product – Precision TAVI - DASI Simulations announced today it has been selected as a member of MedTech Innovator’s 2023 Accelerator program. DASI Simulations is the only Ohio-based start-up selected for the 2023 cohort.
Precision TAVI is the first FDA approved predictive modeling tool for medical teams planning TAVR procedures.
DASI Named One of Columbus' top startups and innovators for 2022 DASI Simulations is excited to announce that we have been named one of Columbus' top startups and innovators. Columbus,…
TechOhio: This Ohio Startup Wants to Give Heart Surgeons an Innovative New Resource How DASI Simulations wants to combat heart disease through their revolutionary techhttps://youtu.be/CP--1SZ_Zqw Read original story on techohio…
DASI Featured in Advances in Aortic Valve Surgery webinar During this special webinar, you will learn how medical experts are using DASI Simulations’ 3D imaging technologies, artificial intelligence, and minimally-invasive…
We perform advanced individualized computational predictive modeling powered by artificial intelligence and computer vision to better plan for improved patient outcomes and reduced costs associated with Structural Heart Disease.